Seth Klarman - Baupost Group
Holding/activity history for Cascadian Therapeutics Inc (CASC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q1 | 0 | 0.00 | Sell 100.00% | 0.32 | SEC | ||
| 2017 Q4 | 8,721,079 | 0.32 | $3.70 | $32,268,000 | SEC | ||
| 2017 Q3 | 8,721,079 | 0.45 | $4.09 | $35,669,000 | SEC | ||
| 2017 Q2 | 8,721,079 | 0.39 | $3.72 | $32,399,000 | SEC | ||
| 2017 Q1 | 8,721,079 | 0.44 | Add 109.31% | 0.23 | $4.14 | $36,105,000 | SEC |
| 2016 Q4 | 4,166,666 | 0.24 | Buy | 0.24 | $4.31 | $17,958,000 | SEC |